2010

8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...

Read More >
Meet us

The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...

Read More >

Zealand Pharma

Zealand Pharma is a biopharmaceutical company dedicated to the discovery and development of innovative peptide-based drugs. The products target diseases and symptoms of significant unmet clinical need and commercial potential.

Since 1999, Zealand’s scientists have built a pipeline of compounds among which many have reached the clinical development stage. For the time being Zealand Pharma has one compound in clinical phase III development, one compound in clinical phase II development and three compounds in clinical phase I development. In addition, two compounds are in pre-clinical development.

As part of the Company’s operations, Zealand Pharma has formed clinical development partnerships with leading pharmaceutical companies sanofi-aventis, Wyeth (now Pfizer) and Helsinn Healthcare.

Zealand Pharma is based in the Copenhagen area.

Annual Report 2009 Fact Sheet Partnering Flyer